D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Microbiology D-index 96 Citations 29,478 498 World Ranking 113 National Ranking 57
Medicine D-index 70 Citations 14,335 285 World Ranking 15295 National Ranking 7948

Overview

What is he best known for?

The fields of study he is best known for:

  • Antibiotics
  • Bacteria
  • Microbiology

His primary areas of study are Microbiology, Broth microdilution, Antimicrobial, Antibacterial agent and Staphylococcus aureus. Microbiology is represented through his Meropenem, Acinetobacter, Antibiotic resistance, Imipenem and Sentry research. His Meropenem study combines topics from a wide range of disciplines, such as Ceftazidime, Klebsiella pneumoniae and Tazobactam.

While the research belongs to areas of Broth microdilution, Helio S. Sader spends his time largely on the problem of Cephalosporin, intersecting his research to questions surrounding Ceftaroline fosamil. Helio S. Sader has researched Antimicrobial in several fields, including Polymyxin B and Drug resistance. His Antibacterial agent research includes elements of Gram-Positive Cocci and Potency.

His most cited work include:

  • International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobial surveillance program. (479 citations)
  • Emerging Importance of Multidrug-Resistant Acinetobacter Species and Stenotrophomonas maltophilia as Pathogens in Seriously Ill Patients: Geographic Patterns, Epidemiological Features, and Trends in the SENTRY Antimicrobial Surveillance Program (1997–1999) (378 citations)
  • International Surveillance of Bloodstream Infections Due to Candida Species: Frequency of Occurrence and Antifungal Susceptibilities of Isolates Collected in 1997 in the United States, Canada, and South America for the SENTRY Program (270 citations)

What are the main themes of his work throughout his whole career to date?

His primary areas of investigation include Microbiology, Broth microdilution, Antimicrobial, Staphylococcus aureus and Antibacterial agent. His studies in Microbiology integrate themes in fields like Vancomycin, Daptomycin and Linezolid. The concepts of his Broth microdilution study are interwoven with issues in Acinetobacter, Pseudomonas aeruginosa, Ceftazidime, Cephalosporin and Klebsiella pneumoniae.

His Antimicrobial research incorporates elements of Antibiotic resistance, Drug resistance and Intensive care medicine. Antibacterial agent is a subfield of Antibiotics that Helio S. Sader explores. His work carried out in the field of Meropenem brings together such families of science as Piperacillin, Tazobactam, Imipenem, Amikacin and Colistin.

He most often published in these fields:

  • Microbiology (85.35%)
  • Broth microdilution (33.07%)
  • Antimicrobial (32.28%)

What were the highlights of his more recent work (between 2016-2021)?

  • Microbiology (85.35%)
  • Antimicrobial (32.28%)
  • Broth microdilution (33.07%)

In recent papers he was focusing on the following fields of study:

Helio S. Sader focuses on Microbiology, Antimicrobial, Broth microdilution, Staphylococcus aureus and Ceftazidime/avibactam. Helio S. Sader works in the field of Microbiology, focusing on Meropenem in particular. In his study, Ceftolozane and Aztreonam is strongly linked to Avibactam, which falls under the umbrella field of Antimicrobial.

His Broth microdilution research includes themes of Colistin, Levofloxacin, Veterinary medicine, Cephalosporin and Antibiotic resistance. Helio S. Sader works mostly in the field of Staphylococcus aureus, limiting it down to topics relating to Streptococcus pneumoniae and, in certain cases, Penicillin and Tigecycline. His study in Ceftazidime/avibactam is interdisciplinary in nature, drawing from both Piperacillin/tazobactam, Enterobacter cloacae and Internal medicine.

Between 2016 and 2021, his most popular works were:

  • The Microbiology of Bloodstream Infection: 20-Year Trends from the SENTRY Antimicrobial Surveillance Program. (59 citations)
  • Pseudomonas aeruginosa Antimicrobial Susceptibility Results from Four Years (2012 to 2015) of the International Network for Optimal Resistance Monitoring Program in the United States (56 citations)
  • Antimicrobial Activity of Ceftazidime-Avibactam Tested against Multidrug-Resistant Enterobacteriaceae and Pseudomonas aeruginosa Isolates from U.S. Medical Centers, 2013 to 2016 (55 citations)

In his most recent research, the most cited papers focused on:

  • Antibiotics
  • Bacteria
  • Staphylococcus aureus

His scientific interests lie mostly in Microbiology, Broth microdilution, Antimicrobial, Enterobacteriaceae and Staphylococcus aureus. The study incorporates disciplines such as Pseudomonas aeruginosa and Klebsiella pneumoniae in addition to Microbiology. His work deals with themes such as Pneumonia, Ceftazidime, Cefepime, Acinetobacter and Meropenem, which intersect with Broth microdilution.

The Antimicrobial study combines topics in areas such as Avibactam, Antibiotic resistance, Multiple drug resistance and Bacterial pneumonia. His work on Enterococcus faecalis and Daptomycin as part of general Staphylococcus aureus study is frequently connected to Food and drug administration, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them. His studies deal with areas such as Enterococcus faecium and Linezolid, Vancomycin, Dalbavancin, Ceftobiprole as well as Enterococcus faecalis.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobial surveillance program.

M. A. Pfaller;D. J. Diekema;R. N. Jones;H. S. Sader.
Journal of Clinical Microbiology (2001)

763 Citations

Emerging Importance of Multidrug-Resistant Acinetobacter Species and Stenotrophomonas maltophilia as Pathogens in Seriously Ill Patients: Geographic Patterns, Epidemiological Features, and Trends in the SENTRY Antimicrobial Surveillance Program (1997–1999)

Ana Cristina Gales;Ana Cristina Gales;R. N. Jones;K. R. Forward;J. Linares.
Clinical Infectious Diseases (2001)

551 Citations

International Surveillance of Bloodstream Infections Due to Candida Species: Frequency of Occurrence and Antifungal Susceptibilities of Isolates Collected in 1997 in the United States, Canada, and South America for the SENTRY Program

M. A. Pfaller;R. N. Jones;G. V. Doern;H. S. Sader.
Journal of Clinical Microbiology (1998)

405 Citations

International surveillance of blood stream infections due to Candida species in the European SENTRY program: species distribution and antifungal susceptibility including the investigational triazole and echinocandin agents

M.A Pfaller;R.N Jones;G.V Doern;A.C Fluit.
Diagnostic Microbiology and Infectious Disease (1999)

379 Citations

Global assessment of the antimicrobial activity of polymyxin B against 54 731 clinical isolates of Gram-negative bacilli: report from the SENTRY antimicrobial surveillance programme (2001–2004)

A.C. Gales;R.N. Jones;H.S. Sader.
Clinical Microbiology and Infection (2006)

378 Citations

Survey of blood stream infections attributable to gram-positive cocci: frequency of occurrence and antimicrobial susceptibility of isolates collected in 1997 in the United States, Canada, and Latin America from the SENTRY antimicrobial surveillance program

M.A Pfaller;R.N Jones;G.V Doern;H.S Sader.
Diagnostic Microbiology and Infectious Disease (1999)

338 Citations

Dissemination in distinct Brazilian regions of an epidemic carbapenem-resistant Pseudomonas aeruginosa producing SPM metallo-β-lactamase

Ana C. Gales;Liana C. Menezes;Suzane Silbert;Hélio S. Sader.
Journal of Antimicrobial Chemotherapy (2003)

282 Citations

Antimicrobial resistance among Gram-negative bacilli isolated from Latin America: results from SENTRY Antimicrobial Surveillance Program (Latin America, 2008-2010).

Ana C. Gales;Mariana Castanheira;Ronald N. Jones;Hélio S. Sader.
Diagnostic Microbiology and Infectious Disease (2012)

281 Citations

Antimicrobial Susceptibility and Epidemiology of a Worldwide Collection of Chryseobacterium spp.: Report from the SENTRY Antimicrobial Surveillance Program (1997-2001)

Jeffrey T. Kirby;Helio S. Sader;Timothy R. Walsh;Ronald N. Jones.
Journal of Clinical Microbiology (2004)

266 Citations

Assessment of pathogen occurrences and resistance profiles among infected patients in the intensive care unit: report from the SENTRY Antimicrobial Surveillance Program (North America, 2001).

Jennifer M Streit;Ronald N Jones;Helio S Sader;Thomas R Fritsche.
International Journal of Antimicrobial Agents (2004)

256 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Helio S. Sader

Ronald N. Jones

Ronald N. Jones

JMI Laboratories

Publications: 189

David P. Nicolau

David P. Nicolau

Hartford Hospital

Publications: 120

Michael J. Rybak

Michael J. Rybak

Eugene Applebaum College of Pharmacy and Health Sciences

Publications: 108

Matthew E. Falagas

Matthew E. Falagas

Alfa Institute of Biomedical Sciences

Publications: 87

James A. Karlowsky

James A. Karlowsky

University of Manitoba

Publications: 77

Ana C. Gales

Ana C. Gales

Federal University of Sao Paulo

Publications: 77

Po-Ren Hsueh

Po-Ren Hsueh

National Taiwan University

Publications: 74

Michael A. Pfaller

Michael A. Pfaller

JMI Laboratories

Publications: 73

Daryl J. Hoban

Daryl J. Hoban

University of Manitoba

Publications: 72

George G. Zhanel

George G. Zhanel

University of Manitoba

Publications: 68

Rodrigo E. Mendes

Rodrigo E. Mendes

JMI Laboratories

Publications: 66

Robert K. Flamm

Robert K. Flamm

Janssen (Belgium)

Publications: 63

Robert A. Bonomo

Robert A. Bonomo

United States Department of Veterans Affairs

Publications: 62

Matteo Bassetti

Matteo Bassetti

University of Genoa

Publications: 61

David L. Paterson

David L. Paterson

University of Queensland

Publications: 55

Mariana Castanheira

Mariana Castanheira

JMI Laboratories

Publications: 53

Something went wrong. Please try again later.